Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)

The location of a major antigenic determinant involved in the neutralization of a flavivirus, yellow fever virus (YF), has been defined in terms of its position in the amino acid sequence of the E protein. Neutralization escape variants of the 17D vaccine strain of YF were selected with two neutrali...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virology (New York, N.Y.) N.Y.), 1987, Vol.161 (2), p.474-478
Hauptverfasser: Lobigs, M., Dalgarno, L., Schlesinger, J.J., Weir, R.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 478
container_issue 2
container_start_page 474
container_title Virology (New York, N.Y.)
container_volume 161
creator Lobigs, M.
Dalgarno, L.
Schlesinger, J.J.
Weir, R.C.
description The location of a major antigenic determinant involved in the neutralization of a flavivirus, yellow fever virus (YF), has been defined in terms of its position in the amino acid sequence of the E protein. Neutralization escape variants of the 17D vaccine strain of YF were selected with two neutralizing monoclonal antibodies. Nucleotide sequencing of the envelope protein genes (E and M) of the variants showed that in each variant there was a single nucleotide change in the E gene leading to a nonconservative amino acid substitution in the E protein at position 71 or 72. The changes are in a region of the E protein which is hydrophilic, rich in cysteine residues, and not conserved between flavivirus subgroups. Since the selecting monoclonal antibodies neutralize attenuated 17D and virulent Asibi strains of YF with equal efficiency ( J. J. Schlesinger, M. W. Brandriss, and T. P. Monath, 1983, Virology 125, 8–17), it can be concluded that the neutralization determinant defined for 17D YF is also present in Asibi YF.
doi_str_mv 10.1016/0042-6822(87)90141-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77854777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0042682287901413</els_id><sourcerecordid>77854777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-f63cdf7225b7e218348ea06628db833ada282f4724a05bde7f61adf842479cf83</originalsourceid><addsrcrecordid>eNqFkUtLAzEUhYMoWh__QCELEV2MJpnMJN0I4hsKbnQd0uQGI9OMJpmK_npTW7rUVbi53zkczkXokJJzSmh7QQhnVSsZO5XibEwop1W9gUaUjNuK1JxuotEa2UG7Kb2RMgtBttE247zljI2QnfRGZ98H3DuscYAhR9357-WfhQxx5oMOGfuA8yvgW_we-wz-V_AFXdd_YgdziHju45DwKRU3eK6N8QFwKmY-nO2jLae7BAerdw-93N0-Xz9Uk6f7x-urSWUaynLl2tpYJxhrpgIYlTWXoEnbMmmnsq611UwyxwXjmjRTC8K1VFsnOeNibJys99DJ0rdE_BggZTXzyZSMOkA_JCWEbEoB4l-QcimIIKSAfAma2KcUwan36Gc6filK1OIKalGxWlSspFC_V1B1kR2t_IfpDOxatKq97I9Xe52M7lzUwfi0xkQjJaPjgl0uMSilzT1ElYyHYMD6CCYr2_u_c_wAzLSiUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14870700</pqid></control><display><type>article</type><title>Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lobigs, M. ; Dalgarno, L. ; Schlesinger, J.J. ; Weir, R.C.</creator><creatorcontrib>Lobigs, M. ; Dalgarno, L. ; Schlesinger, J.J. ; Weir, R.C.</creatorcontrib><description>The location of a major antigenic determinant involved in the neutralization of a flavivirus, yellow fever virus (YF), has been defined in terms of its position in the amino acid sequence of the E protein. Neutralization escape variants of the 17D vaccine strain of YF were selected with two neutralizing monoclonal antibodies. Nucleotide sequencing of the envelope protein genes (E and M) of the variants showed that in each variant there was a single nucleotide change in the E gene leading to a nonconservative amino acid substitution in the E protein at position 71 or 72. The changes are in a region of the E protein which is hydrophilic, rich in cysteine residues, and not conserved between flavivirus subgroups. Since the selecting monoclonal antibodies neutralize attenuated 17D and virulent Asibi strains of YF with equal efficiency ( J. J. Schlesinger, M. W. Brandriss, and T. P. Monath, 1983, Virology 125, 8–17), it can be concluded that the neutralization determinant defined for 17D YF is also present in Asibi YF.</description><identifier>ISSN: 0042-6822</identifier><identifier>EISSN: 1096-0341</identifier><identifier>DOI: 10.1016/0042-6822(87)90141-3</identifier><identifier>PMID: 2446422</identifier><identifier>CODEN: VIRLAX</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Antibodies, Monoclonal ; Antigens, Viral - analysis ; Antigens, Viral - genetics ; Arboviroses ; Biological and medical sciences ; Epitopes ; Fundamental and applied biological sciences. Psychology ; Genes, Viral ; Human viral diseases ; Infectious diseases ; Medical sciences ; Microbiology ; Molecular Sequence Data ; Morphology, structure, chemical composition, physicochemical properties ; Neutralization Tests ; Tropical medicine ; Tropical viral diseases ; Viral diseases ; Viral Proteins - genetics ; Viral Proteins - immunology ; Viral Vaccines - immunology ; Virology ; Yellow fever ; yellow fever virus ; Yellow fever virus - immunology</subject><ispartof>Virology (New York, N.Y.), 1987, Vol.161 (2), p.474-478</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-f63cdf7225b7e218348ea06628db833ada282f4724a05bde7f61adf842479cf83</citedby><cites>FETCH-LOGICAL-c512t-f63cdf7225b7e218348ea06628db833ada282f4724a05bde7f61adf842479cf83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0042682287901413$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7588219$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2446422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lobigs, M.</creatorcontrib><creatorcontrib>Dalgarno, L.</creatorcontrib><creatorcontrib>Schlesinger, J.J.</creatorcontrib><creatorcontrib>Weir, R.C.</creatorcontrib><title>Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)</title><title>Virology (New York, N.Y.)</title><addtitle>Virology</addtitle><description>The location of a major antigenic determinant involved in the neutralization of a flavivirus, yellow fever virus (YF), has been defined in terms of its position in the amino acid sequence of the E protein. Neutralization escape variants of the 17D vaccine strain of YF were selected with two neutralizing monoclonal antibodies. Nucleotide sequencing of the envelope protein genes (E and M) of the variants showed that in each variant there was a single nucleotide change in the E gene leading to a nonconservative amino acid substitution in the E protein at position 71 or 72. The changes are in a region of the E protein which is hydrophilic, rich in cysteine residues, and not conserved between flavivirus subgroups. Since the selecting monoclonal antibodies neutralize attenuated 17D and virulent Asibi strains of YF with equal efficiency ( J. J. Schlesinger, M. W. Brandriss, and T. P. Monath, 1983, Virology 125, 8–17), it can be concluded that the neutralization determinant defined for 17D YF is also present in Asibi YF.</description><subject>Amino Acid Sequence</subject><subject>Antibodies, Monoclonal</subject><subject>Antigens, Viral - analysis</subject><subject>Antigens, Viral - genetics</subject><subject>Arboviroses</subject><subject>Biological and medical sciences</subject><subject>Epitopes</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes, Viral</subject><subject>Human viral diseases</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Molecular Sequence Data</subject><subject>Morphology, structure, chemical composition, physicochemical properties</subject><subject>Neutralization Tests</subject><subject>Tropical medicine</subject><subject>Tropical viral diseases</subject><subject>Viral diseases</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - immunology</subject><subject>Viral Vaccines - immunology</subject><subject>Virology</subject><subject>Yellow fever</subject><subject>yellow fever virus</subject><subject>Yellow fever virus - immunology</subject><issn>0042-6822</issn><issn>1096-0341</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtLAzEUhYMoWh__QCELEV2MJpnMJN0I4hsKbnQd0uQGI9OMJpmK_npTW7rUVbi53zkczkXokJJzSmh7QQhnVSsZO5XibEwop1W9gUaUjNuK1JxuotEa2UG7Kb2RMgtBttE247zljI2QnfRGZ98H3DuscYAhR9357-WfhQxx5oMOGfuA8yvgW_we-wz-V_AFXdd_YgdziHju45DwKRU3eK6N8QFwKmY-nO2jLae7BAerdw-93N0-Xz9Uk6f7x-urSWUaynLl2tpYJxhrpgIYlTWXoEnbMmmnsq611UwyxwXjmjRTC8K1VFsnOeNibJys99DJ0rdE_BggZTXzyZSMOkA_JCWEbEoB4l-QcimIIKSAfAma2KcUwan36Gc6filK1OIKalGxWlSspFC_V1B1kR2t_IfpDOxatKq97I9Xe52M7lzUwfi0xkQjJaPjgl0uMSilzT1ElYyHYMD6CCYr2_u_c_wAzLSiUA</recordid><startdate>1987</startdate><enddate>1987</enddate><creator>Lobigs, M.</creator><creator>Dalgarno, L.</creator><creator>Schlesinger, J.J.</creator><creator>Weir, R.C.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>1987</creationdate><title>Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)</title><author>Lobigs, M. ; Dalgarno, L. ; Schlesinger, J.J. ; Weir, R.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-f63cdf7225b7e218348ea06628db833ada282f4724a05bde7f61adf842479cf83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Amino Acid Sequence</topic><topic>Antibodies, Monoclonal</topic><topic>Antigens, Viral - analysis</topic><topic>Antigens, Viral - genetics</topic><topic>Arboviroses</topic><topic>Biological and medical sciences</topic><topic>Epitopes</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes, Viral</topic><topic>Human viral diseases</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Molecular Sequence Data</topic><topic>Morphology, structure, chemical composition, physicochemical properties</topic><topic>Neutralization Tests</topic><topic>Tropical medicine</topic><topic>Tropical viral diseases</topic><topic>Viral diseases</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - immunology</topic><topic>Viral Vaccines - immunology</topic><topic>Virology</topic><topic>Yellow fever</topic><topic>yellow fever virus</topic><topic>Yellow fever virus - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lobigs, M.</creatorcontrib><creatorcontrib>Dalgarno, L.</creatorcontrib><creatorcontrib>Schlesinger, J.J.</creatorcontrib><creatorcontrib>Weir, R.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Virology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lobigs, M.</au><au>Dalgarno, L.</au><au>Schlesinger, J.J.</au><au>Weir, R.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)</atitle><jtitle>Virology (New York, N.Y.)</jtitle><addtitle>Virology</addtitle><date>1987</date><risdate>1987</risdate><volume>161</volume><issue>2</issue><spage>474</spage><epage>478</epage><pages>474-478</pages><issn>0042-6822</issn><eissn>1096-0341</eissn><coden>VIRLAX</coden><abstract>The location of a major antigenic determinant involved in the neutralization of a flavivirus, yellow fever virus (YF), has been defined in terms of its position in the amino acid sequence of the E protein. Neutralization escape variants of the 17D vaccine strain of YF were selected with two neutralizing monoclonal antibodies. Nucleotide sequencing of the envelope protein genes (E and M) of the variants showed that in each variant there was a single nucleotide change in the E gene leading to a nonconservative amino acid substitution in the E protein at position 71 or 72. The changes are in a region of the E protein which is hydrophilic, rich in cysteine residues, and not conserved between flavivirus subgroups. Since the selecting monoclonal antibodies neutralize attenuated 17D and virulent Asibi strains of YF with equal efficiency ( J. J. Schlesinger, M. W. Brandriss, and T. P. Monath, 1983, Virology 125, 8–17), it can be concluded that the neutralization determinant defined for 17D YF is also present in Asibi YF.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>2446422</pmid><doi>10.1016/0042-6822(87)90141-3</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0042-6822
ispartof Virology (New York, N.Y.), 1987, Vol.161 (2), p.474-478
issn 0042-6822
1096-0341
language eng
recordid cdi_proquest_miscellaneous_77854777
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Amino Acid Sequence
Antibodies, Monoclonal
Antigens, Viral - analysis
Antigens, Viral - genetics
Arboviroses
Biological and medical sciences
Epitopes
Fundamental and applied biological sciences. Psychology
Genes, Viral
Human viral diseases
Infectious diseases
Medical sciences
Microbiology
Molecular Sequence Data
Morphology, structure, chemical composition, physicochemical properties
Neutralization Tests
Tropical medicine
Tropical viral diseases
Viral diseases
Viral Proteins - genetics
Viral Proteins - immunology
Viral Vaccines - immunology
Virology
Yellow fever
yellow fever virus
Yellow fever virus - immunology
title Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T18%3A15%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Location%20of%20a%20neutralization%20determinant%20in%20the%20E%20protein%20of%20yellow%20fever%20virus%20(17D%20vaccine%20strain)&rft.jtitle=Virology%20(New%20York,%20N.Y.)&rft.au=Lobigs,%20M.&rft.date=1987&rft.volume=161&rft.issue=2&rft.spage=474&rft.epage=478&rft.pages=474-478&rft.issn=0042-6822&rft.eissn=1096-0341&rft.coden=VIRLAX&rft_id=info:doi/10.1016/0042-6822(87)90141-3&rft_dat=%3Cproquest_cross%3E77854777%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14870700&rft_id=info:pmid/2446422&rft_els_id=0042682287901413&rfr_iscdi=true